Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Aug;27(8):1403-1417.
doi: 10.1002/ejhf.3417. Epub 2024 Aug 21.

Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment

Affiliations
Meta-Analysis

Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment

Mingming Yang et al. Eur J Heart Fail. 2025 Aug.

Abstract

Aims: Although the prevalence of heart failure (HF) increases markedly with advancing age, surprisingly little is known about HF in the very elderly. The aim of this study was to describe the clinical characteristics and outcomes of octogenarians with HF.

Methods and results: Individual participant meta-analysis of patients with HF and reduced, mildly reduced, and preserved ejection fraction (HFrEF, HFmrEF, and HFpEF, respectively) enrolled in eight large randomized trials. Overall, the proportion of octogenarians was 1518 of 20 168 patients (7.5%) with HFrEF, 610 of 4609 (13.2%) with HFmrEF, and 3130 of 15 354 (20.4%) with HFpEF. Regardless of HF phenotype, octogenarian patients were more often female and had more comorbidities, more symptoms and signs of congestion, and worse health status (but not quality of life), in comparison to patients aged <80 years. The incidence (per 100 person-years) of the composite of cardiovascular death or HF hospitalization was 13.3 (95% confidence interval [CI] 12.7-14.0) in octogenarians versus 9.5 (95% CI 9.3-9.7) in non-octogenarians (adjusted hazard ratio [aHR] 1.40, 95% CI 1.32-1.48). Each component of the composite was more frequent in octogenarians with rates of cardiovascular mortality of 7.0 (95% CI 6.5-7.4) per 100 person-years versus 4.9 (95% CI 4.8-5.1) in non-octogenarians (aHR 1.60, 95% CI 1.48-1.72, p < 0.001). Octogenarians received less evidence-based therapy, especially mineralocorticoid receptor antagonists, than younger patients.

Conclusion: Despite worse health status and higher hospitalization and mortality rates, octogenarians were undertreated compared to younger patients.

Keywords: Comorbidities; Geriatric care; Heart failure; Management; Octogenarian.

PubMed Disclaimer

References

    1. Knoema. United States of America – Total population aged 80 years and over. https://knoema.com/atlas/United‐States‐of‐America/topics/Demographics/Ag... (Accessed 31 July 2024).
    1. Organisation for Economic Cooperation and Development (OECD). Health at a Glance 2017. https://www.oecd‐ilibrary.org/social‐issues‐migration‐health/health‐at‐a‐glance‐2017_heal... (Accessed 31 July 2024).
    1. Davies M, Hobbs F, Davis R, Kenkre JE, Roalfe AK, Hare R, et al. Prevalence of left‐ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study. Lancet 2001;358:439–444. https://doi.org/10.1016/s0140‐6736(01)05620‐3
    1. McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al.; DAPA‐HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995–2008. https://doi.org/10.1056/NEJMoa1911303
    1. Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al.; DELIVER Trial Committees and Investigators. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022;387:1089–1098. https://doi.org/10.1056/NEJMoa2206286

Publication types